Tag: COVID-19

Coronavirus is an infectious disease that has been confirmed in more than six and a half million people across the world. You could be at risk of the virus if you develop any of these three serious signs of COVID-19. The UK has officially passed the peak of the coronavirus infection. The government has advised

The COVID-19 pandemic presents new challenges for clinicians caring for infected patients with diabetes, according to new guidance published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. Hospitalized patients with COVID-19 and diabetes need to receive glucose-lowering therapy in addition to other complex medical management as a way of minimizing risk for complications

Anti-malaria drug hydroxychloroquine taken by Trump does NOT protect people from developing COVID-19 after they have been exposed to someone with the illness, study finds Researchers gave hydroxychloroquine to half of a group of 821 people who had been exposed to coronavirus and the other half a placebo regimen  Of the 107 people who fell

If a child is infected with the new coronavirus, being obese appears to greatly raise the odds for developing a severe form of COVID-19, a new study finds. The report was based on 50 cases of pediatric COVID-19 severe enough to require admission to a New York City hospital. Eleven (22%) of the 50 kids

It begins with shortness of breath. And for approximately one third of patients, acute respiratory distress syndrome, or ARDS, ends in death. For those who survive, their lives are often turned upside-down. Michigan Medicine researchers have been investigating the downstream effects of ARDS for years. As the COVID-19 pandemic rages on, their work has relevance

The global race for a COVID-19 vaccine boils down to some critical questions: How much must the shots rev up someone’s immune system to really work? And could revving it the wrong way cause harm? Even as companies recruit tens of thousands of people for larger vaccine studies this summer, behind the scenes scientists still

To understand how any given disease affects the body, scientists need a wide array of tools. One of the most valuable and indispensable instruments in their toolkit are clinical samples—small amounts of blood, urine, mucus, spit and tissue that can be used to study disease in a patient. Now, a team led by Harvard Medical

The Coronavirus pandemic has the world firmly in its grip: More than five million people were infected worldwide with the novel pathogen, Sars-CoV-2 – 179.928 of them so far in Germany. Top virologist criticized Corona-panic: "Too many Fears geschürt&quot were; Major events such as the carnival session in Gangelt play according to the assessment of

(HealthDay)—Let’s say you’re one of the more than 1.7 million people in the United States who’ve contracted COVID-19, and you’ve been fortunate enough to shake off the virus and recover. What happens when you encounter the COVID-19 coronavirus again? Reinfection is a major concern among public health officials as the nation moves toward reopening the

COVID-19: infections not only affect the lungs The novel Coronavirus SARS-CoV-2 has been associated with cough, fever and respiratory ailments. However, there is evidence that COVID-19 can also have damage to the nervous system. At the beginning of the pandemic, the novel Coronavirus SARS designated CoV-2, often as a respiratory virus. But in the meantime,

One of the most effective measures for containing the transmission of a virus is to identify who an infected person has been in contact and/or crossed paths with, mainly during incubation periods. Aiming to reduce the likelihood of a re-emergence of the pandemic when normal routines resume, Carmetry, a company at the UMH Scientific Park,

A recent review paper from an international research group involving Hokkaido University and the University of Yamanashi in Japan shows how wastewater could provide a useful tool for monitoring COVID-19 and highlights the further research needed to develop this as a viable method for tracking virus outbreaks. This research was published in Science of the

The Coronavirus pandemic, keeps the world in breath: More than 5 million people globally have become infected with the novel Sars-CoV-2 – 178.568 of them so far in Germany. Covid-19-News from Germany and around the world – the top stories: proposed resolution: the Federal government wants to contact restrictions soon loosen (14.29 hrs) After infection

COVID-19: blood thinners do not settle In scientific studies, it has shown a close connection between the Coronavirus SARS-CoV-2-induced disease COVID-19, and coagulation disorders. In addition, it was found that many patients who are severely Ill thrombosis and pulmonary embolism. Experts underline the fact that heart patients should not stop your blood thinners. A long

We often hear that Britain is a “class-based society”. Ask people what class is and you’ll get a wide range of answers—from accent to cultural tastes—leaving you perplexed as to how it might ever be a useful construct to understand much about the realities of British life. But really it’s all about what job you

Detailed analysis from the epicentre of the Italian COVID-19 outbreak describes increase in cases of rare Kawasaki-like disease in young children, adding to reports of similar cases from New York, USA and South East England, UK. Syndrome is rare and experts stress that children remain minimally affected by SARS-CoV-2 infection overall. Doctors in the Bergamo

COVID-19-Ill: Increased Rate of thrombosis and pulmonary embolism COVID-19 results in an unusually high number of cases of disease to thrombosis and pulmonary embolism. This was shown by a study of scientists from Hamburg. The new findings could lead to changes in treatment recommendations for the Coronavirus fell Ill. A few days ago was published

(HealthDay)—The new coronavirus is disproportionately striking minority populations—particularly urban blacks and Navajo Indians living on their reservation. Experts say social and economic factors that predate the COVID-19 crisis may help explain why. “We found that there were large disparities in the proportion of people at risk of COVID-19 from minority and low-income populations,” said study

COVID-19 could have stamped a person “uninsurable” if not for the COVID-19 and tried to purchase an individual health insurance policy could be turned down, charged higher premiums or have follow-up care excluded from coverage. Those considered vulnerable because of conditions such as respiratory problems or early-stage diabetes would have run into a wall of

Drug for treatment of COVID-19 poses a risk for serious side effects Hydroxychloroquine is a drug approved for the treatment of Malaria. Currently, the drug is also used against COVID-19. This is not harmless, because in studies of the Mediterranean, with serious, in some cases, fatal cardiac arrhythmias have been brought in connection. The Federal